EYEPOINT PHARMACEUTICALS INC shareholders Q3 2023

EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 107 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.82 and the average weighting 0.3%.

EYEPOINT PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,490,921$27,892,45924.59%
ACUTA CAPITAL PARTNERS, LLC 300,128$2,398,0231.61%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,492,147$27,902,2551.51%
Cormorant Asset Management, LP 3,200,000$25,568,0001.49%
Samsara BioCapital, LLC 432,000$3,451,6801.06%
Ghost Tree Capital, LLC 325,000$2,596,7500.85%
RA Capital Management 3,370,506$26,930,3430.53%
Ikarian Capital, LLC 4,487$3,585,1130.43%
Affinity Asset Advisors, LLC 155,000$1,238,4500.35%
SECTORAL ASSET MANAGEMENT INC 176,080$1,406,8790.27%
ESSEX INVESTMENT MANAGEMENT CO LLC 207,160$1,655,2080.27%
Corton Capital Inc. 22,682$181,2290.09%
Legato Capital Management LLC 77,401$618,4340.09%
Perceptive Advisors 750,000$2,512,5000.08%
BARD ASSOCIATES INC 19,100$152,6090.06%
INNOVIS ASSET MANAGEMENT LLC 19,031$152,0580.06%
DENALI ADVISORS LLC 13,900$111,0610.04%
SHERBROOKE PARK ADVISERS LLC 12,620$100,8340.03%
Dynamic Technology Lab Private Ltd 38,587$3080.03%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,736,503$13,874,6590.03%
External links

This page lists EYEPOINT PHARMACEUTICALS INC's shareholders in Q3 2023. To view EYEPOINT PHARMACEUTICALS INC's shareholder history, click here.